Endometrial cancer: molecular classification and future treatments.
BMJ Med
; 1(1): e000152, 2022.
Article
in En
| MEDLINE
| ID: mdl-36936577
ABSTRACT
The treatment for endometrial cancer is rapidly evolving with the development of molecular analysis and novel strategies. Surgical resection, cytotoxic chemotherapy, endocrine or hormonal treatment, and radiation have been the staples of treatment for decades. However, precision based approaches for tumours are rapidly becoming a part of these strategies. Biomarker driven treatments are now a part of primary and recurrent treatment algorithms. This review aims to describe the current state of molecular analysis and treatment for endometrial cancer as well as to elucidate potential approaches for the near future.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
BMJ Med
Year:
2022
Document type:
Article
Affiliation country:
United States